from: http://www.sec.gov/Archives/edgar/data/1006195/000095015304000484/0000950153-04-000484.txt

-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 IpI/S1Fuarc77fF+u0v1zfTAaX+BhvAD2bknb1DWRUYd15r1+zKL6+0Wh4baKSrN
 Re8dZDLQe0gL5Sgu8vKsnw==

0000950153-04-000484.txt : 20040227
0000950153-04-000484.hdr.sgml : 20040227
20040227155556
ACCESSION NUMBER:		0000950153-04-000484
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20040219
ITEM INFORMATION:		Other events
FILED AS OF DATE:		20040227

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MATRIXX INITIATIVES INC
		CENTRAL INDEX KEY:			0001006195
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				870482806
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31404
		FILM NUMBER:		04635172

	BUSINESS ADDRESS:	
		STREET 1:		2375 EAST CAMELBACK ROAD
		STREET 2:		SUITE 500
		CITY:			PHOENIX
		STATE:			AZ
		ZIP:			85016
		BUSINESS PHONE:		6023875353

	MAIL ADDRESS:	
		STREET 1:		2375 EAST CAMELBACK ROAD
		STREET 2:		SUITE 500
		CITY:			PHOENIX
		STATE:			AZ
		ZIP:			85016

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GUMTECH INTERNATIONAL INC \UT\
		DATE OF NAME CHANGE:	19960202


8-K
1
p68843e8vk.htm
8-K
e8vk
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

February 19, 2004 (Date of earliest event reported)

MATRIXX INITIATIVES, INC.

(Exact Name of Registrant as Specified in its Charter)
         
DELAWARE   0-27646   87-0482806
(State or Other Jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification No.)

4742 North 24th Street, Suite 455
Phoenix, Arizona 85016
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code (602) 387-5353

 


TABLE OF CONTENTS

ITEM 5. OTHER EVENTS
SIGNATURES


Table of Contents

ITEM 5. OTHER EVENTS

Matrixx Initiatives, Inc., the manufacturer of Zicam® Cold Remedy zinc products, convened a two-day meeting of a panel of physicians and scientists to review current information on smell disorders. The meeting was held in response to a poster presentation at the American Rhinological Society in September 2003 alleging an association between the use of Zicam and the onset of smell disorders.

The incidence of smell disorders in the United States is reported at 1-2% of the population. Reported post-marketing subjective complaints of distortion of sense of smell associated with Zicam are well below national levels.

In the opinion of the panel, there is insufficient scientific evidence at this time to determine if zinc gluconate, when used as recommended, affects a person’s ability to smell.

Panel members noted that upper respiratory infection is the most common cause of disorders of smell; and, therefore, any product to treat upper respiratory symptoms may be mistakenly associated with distortion of sense of smell.

The panel recommended additional animal and human studies to further characterize these post-marketing complaints. Study findings are expected to be available in 12 months.

Panel members included Lawrence DeSanto, M.D., Mayo Clinic, Scottsdale; Joseph E. Dohar, M.D., Children’s Hosital of Pittsburgh; Aiden L. Doyle, M.D., FACS, Pharmacetical Consultant, Central Nervous System; Jack M. Gwaltney Jr., M.D., University of Virginia Health System; Kathleen M. Guthrie, Ph.D., Department of Biomedical Science, Florida Atlantic University; Judith K. Jones, M.D., Ph.D., Pharmacoepidemiologist; Bao-Anh Nguyen-Khoa, Pharm. D., M.P.H., Pharmacoepidemiologist; Burton M. Slotnick, Ph.D., Department of Psychology, University of South Florida; Michael Zmuda, Ph.D., Regulatory Consultant.

 


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
  MATRIXX INITIATIVES, INC. (Registrant)
 
   
 
  /s/ William J. Hemelt
 
 
  William J. Hemelt
  Executive Vice President, Chief
  Financial Officer, Treasurer and
  Secretary

Date: February 27, 2004

 

-----END PRIVACY-ENHANCED MESSAGE-----